Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eledon Pharmaceuticals, Inc.

3.73
-0.0800-2.10%
Post-market: 3.800.0700+1.88%19:38 EDT
Volume:589.96K
Turnover:2.24M
Market Cap:223.36M
PE:-11.81
High:3.95
Open:3.83
Low:3.73
Close:3.81
Loading ...

Eledon Pharmaceuticals Announces Updated Data from Phase 1b Trial of Tegoprubart for Kidney Transplant Rejection Prevention at World Transplant Congress 2025

Reuters
·
18 Jul

Updated Data From Eledon Pharmaceuticals’ Ongoing Phase 1B Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to Be Presented at the World Transplant Congress 2025

THOMSON REUTERS
·
18 Jul

Cantor Fitzgerald Keeps Their Buy Rating on Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
10 Jul

Noble Financial Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
10 Jul

Guggenheim Keeps Their Buy Rating on Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
10 Jul

Eledon Pharmaceuticals, Sernova Collaborate to Test Tegoprubart in Type 1 Diabetes

MT Newswires Live
·
09 Jul

Sernova Biotherapeutics Announces Collaboration With Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

THOMSON REUTERS
·
09 Jul

Sernova Biotherapeutics Inc - Eledon to Supply Tegoprubart for Transplant Rejection Prevention

THOMSON REUTERS
·
09 Jul

Eledon Pharmaceuticals Announces R&D Day to Highlight Tegoprubart's Clinical Development in Transplantation

Reuters
·
26 Jun

Eledon Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
18 Jun

Eledon Pharmaceuticals Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $9

THOMSON REUTERS
·
18 Jun

Eledon Pharmaceuticals assumed with a Buy at H.C. Wainwright

TIPRANKS
·
18 Jun

Eledon Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
13 Jun

Eledon Pharmaceuticals (ELDN) Receives a Buy from Noble Financial

TIPRANKS
·
19 May

Eledon Pharma Q1 EPS $(0.08) Beats $(0.30) Estimate

Benzinga
·
15 May

Eledon Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Eledon Pharmaceuticals Inc - on Track to Report Phase 2 Bestow Trial Results in Q4 2025

THOMSON REUTERS
·
15 May

Press Release: Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

Dow Jones
·
15 May

Eledon Pharmaceuticals Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
05 May

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) has caught the attention of institutional investors who hold a sizeable 46% stake

Simply Wall St.
·
02 May